![](https://monteverdelaw.com/wp-content/uploads/case-logo/cardiovascular-systems-inc.png)
Cardiovascular Systems, Inc. (NASDAQ: CSII), relating to its proposed sale to Abbott Laboratories. Under the terms of the agreement, CSII shareholders are expected to receive $20.00 in cash per common share they own.
Cardiovascular Systems, Inc. (NASDAQ: CSII), relating to its proposed sale to Abbott Laboratories. Under the terms of the agreement, CSII shareholders are expected to receive $20.00 in cash per common share they own.